| Literature DB >> 26707129 |
Shu-Sheng Jiao1, Xian-Le Bu1, Yu-Hui Liu1, Chi Zhu1, Qing-Hua Wang1, Lin-Lin Shen1, Cheng-Hui Liu1, Ye-Ran Wang1, Xiu-Qing Yao1, Yan-Jiang Wang2.
Abstract
Alzheimer's disease (AD) is the most common form of dementia among the elderly, characterized by parenchymal and vascular beta-amyloid (Aβ) burden, tau pathology, neuroinflammation, and loss of neurons and synapses. There is a clear sex difference in the prevalence of AD. However, sex differences in AD-type pathologies have not been systematically documented. Applying 12-month-old female and male APP/PS1 mice as a model, we investigated the sex dimorphism in these major pathological indices. Compared with male APP/PS1 mice, the females exhibited higher parenchymal Aβ burdens, with the sex difference in hippocampus being the most significant. Female APP/PS1 mice had more severe cerebral amyloid angiopathy and subsequent microhemorrhage. In addition, female APP/PS1 mice also showed higher levels of phosphorylated tau and proinflammatory cytokines, more severe astrocytosis and microgliosis, and greater neuronal and synaptic degenerations. The present study systematically described a sex dimorphism in AD-type pathologic indices, suggesting that gender should be taken into account in designing studies involving these pathological indices and when interpreting the relevant findings in those studies.Entities:
Keywords: Alzheimer’s disease; Beta-amyloid; Cerebral amyloid angiopathy; Loss of neurons and synapses; Neuroinflammation; Sex dimorphism; Tau pathology
Mesh:
Substances:
Year: 2015 PMID: 26707129 DOI: 10.1007/s12640-015-9589-x
Source DB: PubMed Journal: Neurotox Res ISSN: 1029-8428 Impact factor: 3.911